Population Pharmacokinetic Modeling and Simulation to Support the Regulatory Submission of the Two‐Injection Start Regimen with Aripiprazole Once‐Monthly Long‐Acting Injectable Intramuscular Administration in Japanese Patients with Schizophrenia or Bipolar I Disorder

Yumiko Yamasaki, Tomohiro Sasaki, Antal Martinecz, Mayumi Hasegawa, Kazuo Kuwahara, Ayaka Soga, Kai Yamada, Satoshi Katayama, Kenji Maeda, Takako Ichimura, Yosuke Kawai

Open source

DOI: 10.1002/jcph.70230
Published: 2026-07
Container: The Journal of Clinical Pharmacology
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/jcph.70230,
  title = {Population Pharmacokinetic Modeling and Simulation to Support the Regulatory Submission of the Two‐Injection Start Regimen with Aripiprazole Once‐Monthly Long‐Acting Injectable Intramuscular Administration in Japanese Patients with Schizophrenia or Bipolar I Disorder},
  author = {Yumiko Yamasaki and Tomohiro Sasaki and Antal Martinecz and Mayumi Hasegawa and Kazuo Kuwahara and Ayaka Soga and Kai Yamada and Satoshi Katayama and Kenji Maeda and Takako Ichimura and Yosuke Kawai},
  year = {2026},
  journal = {The Journal of Clinical Pharmacology},
  doi = {10.1002/jcph.70230},
  url = {https://doi.org/10.1002/jcph.70230}
}

RIS

TY  - JOUR
TI  - Population Pharmacokinetic Modeling and Simulation to Support the Regulatory Submission of the Two‐Injection Start Regimen with Aripiprazole Once‐Monthly Long‐Acting Injectable Intramuscular Administration in Japanese Patients with Schizophrenia or Bipolar I Disorder
AU  - Yumiko Yamasaki
AU  - Tomohiro Sasaki
AU  - Antal Martinecz
AU  - Mayumi Hasegawa
AU  - Kazuo Kuwahara
AU  - Ayaka Soga
AU  - Kai Yamada
AU  - Satoshi Katayama
AU  - Kenji Maeda
AU  - Takako Ichimura
AU  - Yosuke Kawai
PY  - 2026
JO  - The Journal of Clinical Pharmacology
DO  - 10.1002/jcph.70230
UR  - https://doi.org/10.1002/jcph.70230
ER  -

APA

Yamasaki, Y., Sasaki, T., Martinecz, A., Hasegawa, M., Kuwahara, K., Soga, A., Yamada, K., Katayama, S., Maeda, K., Ichimura, T., & Kawai, Y. (2026). Population Pharmacokinetic Modeling and Simulation to Support the Regulatory Submission of the Two‐Injection Start Regimen with Aripiprazole Once‐Monthly Long‐Acting Injectable Intramuscular Administration in Japanese Patients with Schizophrenia or Bipolar I Disorder. The Journal of Clinical Pharmacology. https://doi.org/10.1002/jcph.70230

Source records

crossref · retrieved 2026-09-26T23:55:23.870Z